NEW BRUNSWICK, N.J. – Johnson & Johnson (JNJ) on Tuesday reported second-quarter net income of $4 billion.
The New Brunswick, New Jersey-based company said it had profit of $1.43 per share. Earnings, adjusted for non-recurring costs and amortization costs, came to $1.74 per share.
The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.67 per share.
The world’s biggest maker of health care products posted revenue of $18.48 billion in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $17.89 billion.
Johnson & Johnson expects full-year earnings in the range of $6.63 to $6.73 per share, with revenue in the range of $71.5 billion to $72.2 billion.
Johnson & Johnson shares have increased 20 per cent since the beginning of the year, while the Standard & Poor’s 500 index has increased 6 per cent. The stock has risen 22 per cent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JNJ at http://www.zacks.com/ap/JNJ
Keywords: Johnson & Johnson, Earnings Report, Priority Earnings